GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Decipher Labs Ltd (BOM:524752) » Definitions » EV-to-EBIT

Decipher Labs (BOM:524752) EV-to-EBIT : 8.91 (As of Apr. 28, 2025)


View and export this data going back to 1995. Start your Free Trial

What is Decipher Labs EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Decipher Labs's Enterprise Value is ₹73.1 Mil. Decipher Labs's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was ₹8.2 Mil. Therefore, Decipher Labs's EV-to-EBIT for today is 8.91.

The historical rank and industry rank for Decipher Labs's EV-to-EBIT or its related term are showing as below:

BOM:524752' s EV-to-EBIT Range Over the Past 10 Years
Min: -50.87   Med: 7.8   Max: 20647.05
Current: 8.91

During the past 13 years, the highest EV-to-EBIT of Decipher Labs was 20647.05. The lowest was -50.87. And the median was 7.80.

BOM:524752's EV-to-EBIT is ranked better than
77.24% of 681 companies
in the Drug Manufacturers industry
Industry Median: 16.39 vs BOM:524752: 8.91

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Decipher Labs's Enterprise Value for the quarter that ended in Dec. 2024 was ₹151.0 Mil. Decipher Labs's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was ₹8.2 Mil. Decipher Labs's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 5.44%.


Decipher Labs EV-to-EBIT Historical Data

The historical data trend for Decipher Labs's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decipher Labs EV-to-EBIT Chart

Decipher Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.60 13.19 3.77 -2.11 -5.64

Decipher Labs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.84 -5.64 29.59 8.14 18.39

Competitive Comparison of Decipher Labs's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Decipher Labs's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Decipher Labs's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Decipher Labs's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Decipher Labs's EV-to-EBIT falls into.


;
;

Decipher Labs EV-to-EBIT Calculation

Decipher Labs's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=73.119/8.21
=8.91

Decipher Labs's current Enterprise Value is ₹73.1 Mil.
Decipher Labs's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Decipher Labs  (BOM:524752) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Decipher Labs's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 ) =EBIT / Enterprise Value (Q: Dec. 2024 )
=8.21/150.995
=5.44 %

Decipher Labs's Enterprise Value for the quarter that ended in Dec. 2024 was ₹151.0 Mil.
Decipher Labs's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Decipher Labs EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Decipher Labs's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Decipher Labs Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, 4th Floor, Plot No. 94, Sagar Society, Banjara Hills, Hyderabad, TG, IND, 500034
Decipher Labs Ltd, formerly Combat Drugs Ltd is an India-based company engaged in the trading and manufacturing of Pharmaceutical drugs. It also undertakes contract manufacturing services business. The group generates revenue from the sale of its pharmaceutical products.

Decipher Labs Headlines

No Headlines